Intra-abdominal, pelvic, and diabetic foot infections are generally polymicrobial. Antimicrobial resistance occurs commonly, complicating treatment. Among numerous therapeutic options, a beta-lactam with a beta-lactamase inhibitor, and newer fluoroquinolones, may be particularly useful in managing these infections.